These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35042902)

  • 1. Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b.
    Chen Q; Zhou Q; He H; He Y; Yuan Y; Zou Q; Yi W
    Sci Rep; 2022 Jan; 12(1):871. PubMed ID: 35042902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database Analysis.
    Zhang J; Wang W; Wang J; Luo Y; Chen S; Ma F; Xu B; Fan Y
    J Oncol; 2020; 2020():8880727. PubMed ID: 33381180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor-negative and HER2-positive breast cancer?
    Wang C; Zhou Y; Zhu H; Huang W; Chen Z; Mao F; Lin Y; Zhang X; Shen S; Zhong Y; Li Y; Sun Q
    Cancer Med; 2018 Nov; 7(11):5420-5430. PubMed ID: 30277006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort.
    Shen K; Yao L; Zhu J; Gu X; Wang J; Qian W; Zheng Z; Fu D; Wu S
    BMC Cancer; 2022 Aug; 22(1):863. PubMed ID: 35941565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prognostic and treatment between T1a and T1b glottic cancer: a propensity score-matched SEER database analysis.
    Fang L; Tuohuti A; Shi L; Chen X
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3313-3322. PubMed ID: 37039896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer.
    van Ramshorst MS; van der Heiden-van der Loo M; Dackus GM; Linn SC; Sonke GS
    Breast Cancer Res Treat; 2016 Jul; 158(2):361-71. PubMed ID: 27357813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy is of prognostic significance to metaplastic breast cancer.
    Zhang M; Yuan J; Wang M; Zhang M; Chen H
    Sci Rep; 2024 Jan; 14(1):1210. PubMed ID: 38216630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
    Cai W; Zhuang Y; Chen J; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.
    Lee JH; Ryu JM; Lee SK; Chae BJ; Lee JE; Kim SW; Nam SJ; Yu J
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.
    Fasano GA; Bayard S; Chen Y; Varella L; Cigler T; Bensenhaver J; Simmons R; Swistel A; Marti J; Moore A; Andreopoulou E; Ng J; Brandmaier A; Formenti S; Ali H; Davis M; Newman L
    Breast Cancer Res Treat; 2022 Feb; 192(1):163-173. PubMed ID: 35022867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A US Registry-Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast Cancer.
    Parsons BM; Uprety D; Smith AL; Borgert AJ; Dietrich LL
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1311-1320. PubMed ID: 30442732
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification.
    Ichizawa N; Fukutomi T; Iwamoto E; Akashi-Tanaka S
    Jpn J Clin Oncol; 2002 Mar; 32(3):108-9. PubMed ID: 11956306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Metaplastic Breast Cancer Versus Triple-Negative Breast Cancer: A Propensity Score Matching Analysis.
    Tan Y; Yang B; Chen Y; Yan X
    World J Surg; 2023 Dec; 47(12):3192-3202. PubMed ID: 37709983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
    Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
    Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
    Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
    Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
    BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
    Adachi Y; Oze I; Sawaki M; Hattori M; Yoshimura A; Kotani H; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Nozawa K; Takatsuka D; Iwata H
    Breast Cancer; 2021 Sep; 28(5):1087-1095. PubMed ID: 33886077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.
    Kaplan HG; Malmgren JA; Atwood M
    Breast J; 2009; 15(5):454-60. PubMed ID: 19671105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.